Search
Close this search box.
Search
Close this search box.

Seminars

Our Seminar Series

Explore a diverse range of topics and expertise through our seminar series at the Blumberg Institute. Our Industry Speakers series offers valuable industry insights, while the Young Investigator Seminars showcase cutting-edge research. Invited Seminars feature esteemed guests, and Distinguished Seminars highlight profound expertise. Join us in cultivating collaboration, fostering innovation, and promoting academic excellence.

All seminars, unless noted, take place at our headquarters at the Pennsylvania Biotechnology Center at 3805 Old Easton Road, Doylestown, PA 18902, in Room 3100.

No registration required.

Nobel Laureate Dr. Drew Weissman (center, with necktie) presenting in 2023 at the Blumberg Institute.
Dr. Weissman, the Roberts Family Professor of Vaccine Research at the University of Pennsylvania, delivered the Distinguished Speaker Seminar at the Blumberg Institute on March 24, 2023. Less than seven months later, Dr. Weissman was awarded the 2023 Nobel Prize in Medicine or Physiology, along with Katalin Karikó, PhD, adjunct professor of neurosurgery at the University of Pennsylvania.

Upcoming Seminars

Date & Time

Speaker

Topic

July 25, 2024, 11:00 am
(hybrid)

Dr. Brett Tounge, PhD
Co-Founder and Managing Partner, Chairman at Mebias Discovery

The discovery and development of non-addictive analgesics utilizing Mebias’ novel drug discovery platform

August 15, 2024, 11:00 am
(virtual)

Dr. Albert Jeltsch, PhD
Prof. of Biochemistry, University of Stuttgart, German
Analysis of the specificities of DNA and protein methyltransferases leading to novel insights into epigenetic processes
September 19, 2024, 11:00 am
(hybrid)

Dr. Mark Yorek, PhD

tbd

December 12, 2024, 11:00 am
(hybrid)

Dr. Harry Janssen, MD PhD.
Chair Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands

tbd

Recent Seminars

Date

Speaker

Topic

Video Link

(If Available)

June 28, 2024

Dr. Llorente Bonoga, PhD.
Senior Director, GRACS CMC
Enabling First in Human Studies: Regulatory Requirements, Regulatory Documentation and CMC Risks and Mitigations Part 2: “Regulatory CMC Considerations for Clinical Studies”

June 13, 2024

Maarouf Hoteit, MD, AGAF. 
Associate Professor of Clinical Medicine, University of Pennsylvania

Early Detection of Hepatocellular Carcinoma

May 30, 2024

Dr, Manisha Srivastava, PhD. 
Associate Director, GRACS CMC

Enabling First in Human Studies: Regulatory Requirements, Regulatory Documentation and CMC Risks and Mitigations, Part 1: “Global CMC Documentation and CMC Strategies Enabling Global Phase 1 Studies”

May 16, 2024

Heather Finlay, PhD. 
VP Medicinal Chemistry, Exelixis

Why do Drugs Fail and How Can We Do Better?

April 25, 2024

Shihyun You, PhD. 
Professor of Biochemistry, University of Stuttgart, German

Analysis of the specificities of DNA and protein methyltransferases leading to novel insights into epigenetic processes

April 11, 2024

Robert C. Reynolds, PhD
Research Professor of Medicinal Chemistry

Targeted Protein Degradation for Antiviral Drug Discovery

March 28, 2024

Pekka Katajisto, PhD.
Professor, University of Helsinki and Karolinska Institute

Distinguished Speaker Series

March 14, 2024

George Yeoh, BSc (Hons), PhD.
Laboratory Head, Perkins Institute of Medical Research
Liver progenitor/stem cells – a bucket list of experiments.

February 22, 2024

Dr. Theo Heller, MD.
Senior Investigator NIH, Bethesda, MD

HDV: D is for Diabolical, or “Are we Winning Yet?”

January 11, 2024

Yongzhen Liu, PhD.
Postdoctoral Research Fellow in the Department of Molecular Biology at Princeton University

Outstanding Young Scientist Series

X